These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial. Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956 [TBL] [Abstract][Full Text] [Related]
4. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists]. Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914 [TBL] [Abstract][Full Text] [Related]
5. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia. Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935 [TBL] [Abstract][Full Text] [Related]
6. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
7. Long-acting injectable antipsychotics for prevention and management of violent behaviour in psychotic patients. Mohr P; Knytl P; Voráčková V; Bravermanová A; Melicher T Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28869705 [TBL] [Abstract][Full Text] [Related]
8. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Dolder CR; Lacro JP; Jeste DV Psychosom Med; 2003; 65(1):156-62. PubMed ID: 12554828 [TBL] [Abstract][Full Text] [Related]
9. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Byerly MJ; Nakonezny PA; Rush AJ Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269 [TBL] [Abstract][Full Text] [Related]
10. Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study. García Álvarez JC; González Sánchez L; García Resa E; Bonete Llácer JM; Román Rodríguez A; Pecino Esquerdo B; Pérez Martínez E Int J Psychiatry Clin Pract; 2020 Mar; 24(1):10-17. PubMed ID: 31933402 [No Abstract] [Full Text] [Related]
11. The effect of providing patient-specific electronically monitored antipsychotic medication adherence results on the treatment planning of prescribers of outpatients with schizophrenia. Nakonezny PA; Byerly MJ; Pradhan A Psychiatry Res; 2013 Jun; 208(1):9-14. PubMed ID: 23473653 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of Clinician Assessments of Medication Status in the Emergency Setting: A Comparison of Clinician Assessment of Antipsychotic Usage and Plasma Level Determination. Lopez LV; Shaikh A; Merson J; Greenberg J; Suckow RF; Kane JM J Clin Psychopharmacol; 2017 Jun; 37(3):310-314. PubMed ID: 28353490 [TBL] [Abstract][Full Text] [Related]
13. Adherence to treatment and therapeutic strategies in schizophrenic patients: the ADHERE study. Gutiérrez-Casares JR; Cañas F; Rodríguez-Morales A; Hidalgo-Borrajo R; Alonso-Escolano D CNS Spectr; 2010 May; 15(5):327-37. PubMed ID: 20448523 [TBL] [Abstract][Full Text] [Related]
14. Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit. Gilbert JL; Nelson LA; Kriz CR; Liu Y; Iuppa CA; Diefenderfer LA; Elliott ESR; Sommi RW Psychopharmacol Bull; 2019 Jun; 49(2):8-16. PubMed ID: 31308578 [TBL] [Abstract][Full Text] [Related]
15. Communication about adherence to long-term antipsychotic prescribing: an observational study of psychiatric practice. Quirk A; Chaplin R; Hamilton S; Lelliott P; Seale C Soc Psychiatry Psychiatr Epidemiol; 2013 Apr; 48(4):639-47. PubMed ID: 23007293 [TBL] [Abstract][Full Text] [Related]
17. Is the Evidence Strong Enough to Warrant Long-Term Antipsychotic Use in Compulsory Outpatient Treatment? Barnes SS; Badre N Psychiatr Serv; 2016 Jul; 67(7):784-6. PubMed ID: 26975525 [TBL] [Abstract][Full Text] [Related]
18. Clinical Consensus Recommendations for Urine Testing of Adherence to Antipsychotics Among People With Serious Mental Illness. Cohen AN; Collins G; Nucifora FC; Strobel R; Wait DB; Young AS Psychiatr Serv; 2018 Mar; 69(3):345-348. PubMed ID: 29241434 [TBL] [Abstract][Full Text] [Related]
19. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial. Priebe S; Bremner SA; Lauber C; Henderson C; Burns T Health Technol Assess; 2016 Sep; 20(70):1-122. PubMed ID: 27682868 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of financial incentives for long-acting injectable antipsychotic adherence in patients with psychotic and bipolar disorders: a systematic review protocol. Dennis R; Christian R; Palokas M JBI Database System Rev Implement Rep; 2019 Jan; 17(1):43-48. PubMed ID: 30629042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]